ARCHIVES

Small Phase II Study Finds New Oral Agent May Slow Progression Of Difficult Cancer

This article is from The Cancer Letter archive.

Vol. 32 No. 4 | April 24, 2009

Download PDF Visit The Full Archive

Related Articles

NCI Programs: Klausner Plans 20-25% Increase In Funding For Cooperative Groups

November 6, 1998

Agency Asks GnRH Sponsors To Add Warnings On Labels

October 22, 2010

Sandra Horning elected ASCO president-elect.

February 27, 2004

FDA Advisors Oppose Group’s Tamoxifen Trial, But Okay The Idea

July 6, 1990

AACI Recommends Cancer Control Guideline Changes

February 9, 1979

In Brief: Yarbros To Move Frm Missouri To Illinois; Canellos Elected Fellow Of Royal College

February 21, 1992